Pages
AT&T would pay $39 billion for rival
David Gura Sep 22, 2011
Mobile carrier AT&T has agreed to buy No. 4 wireless carrier T-Mobile. The deal would make AT&T the nation's biggest wireless company -- but could leave the market with just two dominant providers.
Warren Buffett bets $9 billion on engine oil
Stacey Vanek Smith Mar 14, 2011
Weeks after Buffett said he had an "itchy" finger for acquisitions, his Berkshire Hathaway agreed to buy industrial chemical firm Lubrizol.
Bids are due for Orange County Register owner
Jeff Tyler Mar 10, 2011
In the digital age, are newspapers companies still worth buying? California's Freedom Communications is on the block and about to find out.
Sprint, T-Mobile resume merger discussions
Gregory Warner Mar 9, 2011
Stock prices jumped yesterday on the announcement that Sprint and T-Mobile resumed discussions of a merger. A merger of the two companies would combine the third- and fourth-largest U.S. wireless providers.
Luxury goods giant buys a piece of watchmaker Bulgari
Stephen Beard Mar 7, 2011
LVMH owns luxury brands from Louis Vuitton to Moet champagne and it now plans to sell watches. It will acquire a major piece of Italian jeweler Bulgari for $5.2 billion. Stephen Beard explains.
Blackstone to buy almost 600 shopping centers
Heidi N. Moore Feb 28, 2011
Betting on American consumers and rebounding property prices, private equity investor Blackstone Group is to buy nearly 600 shopping centers.
MID-DAY UPDATE: stock exchange merger, Egypt, workers' union, and Civil War tourism
Katharine Crnko Feb 18, 2011
Now that the German and New York stock exchanges have tied the knot, it's time to discuss which entity is going to take a new name. Germans think...
Newly merged stock exchanges search for a new name
Stephen Beard Feb 21, 2011
The combined German and New York Stock Exchange must now find a suitable name for the newly merged trading floor. And as Stephen Beard explains, instead of using a brand consultant, the new exchange is going the social media route for suggestions.
Sanofi-Aventis to pay more than $20 bil. for Genzyme
Steve Chiotakis Sep 22, 2011
French pharmaceutical company Sanofi-Aventis will pay more than $20.1 billion for U.S. biotech firm Genzyme. Sanofi will pay $74 per Genzyme share once the deal closes in the second quarter of 2011.
Pharma deal: French Sanofi-Aventis to buy U.S. Genzyme
Eve Troeh Sep 22, 2011
Wednesday brought an end to the long-awaited deal between French pharmaceutical company Sanofi-Aventis and the U.S. biotech firm Genzyme. Sanofi will buy Genzyme for at least $20.1 billion. But the number could go higher if Genzym's drugs-in-development succeed when they go to market, as Eve Troeh explains.
